Scholarly Index
Manuel Mayr
Lung Institute; 33,026 total citations; 471 total publications; best world rank #100
Lung Institute
33,026Total citations
471Total publications
99H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| MicroRNA in disease regulation | Lifetime | 100 | US 39 | 99.47 |
| Metabolomics and Mass Spectrometry Studies | Lifetime | 157 | US 65 | 98.89 |
| Atherosclerosis and Cardiovascular Diseases | Lifetime | 107 | US 55 | 99.02 |
| Circular RNAs in diseases | Lifetime | 158 | US 36 | 98.74 |
| Cancer-related molecular mechanisms research | Lifetime | 417 | US 110 | 98.61 |
| Advanced Proteomics Techniques and Applications | Lifetime | 122 | US 67 | 98.47 |
| Extracellular vesicles in disease | Lifetime | 624 | US 146 | 95.53 |
| Protease and Inhibitor Mechanisms | Lifetime | 664 | US 278 | 96.33 |
| Angiogenesis and VEGF in Cancer | Lifetime | 835 | US 352 | 95.58 |
| Cardiac Fibrosis and Remodeling | Lifetime | 534 | US 197 | 93.52 |
| Calpain Protease Function and Regulation | Lifetime | 509 | US 195 | 83.00 |
| Atherosclerosis and Cardiovascular Diseases | 2021-2025 | 401 | US 88 | 86.03 |
| Connective tissue disorders research | 2021-2025 | 344 | US 81 | 78.93 |
| Cardiac Fibrosis and Remodeling | 2021-2025 | 736 | US 171 | 66.25 |
| Cardiovascular, Neuropeptides, and Oxidative Stress Research | 2021-2025 | 950 | US 127 | 24.48 |